Clinical Trials Directory

Trials / Completed

CompletedNCT01391416

Prevalence Of Hyperhomocysteinemia In Thai Chronic Kidney Disease (CKD) Patients

Prevalence Of Hyperhomocysteinemia In Thai CKD Patients And Relationship To Cardiovascular Events: Subgroup Analysis From Thai SEEK Study

Status
Completed
Phase
Study type
Observational
Enrollment
98 (actual)
Sponsor
Bangkok Metropolitan Administration Medical College and Vajira Hospital · Other Government
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

It is well recognized that patients with chronic kidney disease (CKD) have an increased risk for cardiovascular disease (CVD) and hyperhomocysteinemia appears to be a predictor of future CVD events. Hyperhomocysteinemia has been reported to bo of high prevalence in patients with CKD. The investigators aim to study the prevalence of hyperhomocysteinemia in Thai CKD patients by using Thai Screening and Early Evaluation of Kidney Disease (SEEK) study database and their relationship to CVD.

Detailed description

Ninety eight subjects were sampling from Thai SEEK study database Traditional Traditional risk factors of CVD such as total cholesterol, triglyceride, age, sex, history of smoking and blood pressure levels were examined and recorded. Stored sera of these subjects were analyzed for the total homocysteine (tHcy) level. Analysis of variance was used to evaluate the different of mean tHcy among groups

Conditions

Timeline

Start date
2010-06-01
Primary completion
2010-11-01
Completion
2011-01-01
First posted
2011-07-12
Last updated
2011-07-12

Source: ClinicalTrials.gov record NCT01391416. Inclusion in this directory is not an endorsement.